Most advertised drugs on U.S. TV 2019
Humira, Xeljanz and Eliquis were the top three most advertised drugs on U.S. TV in 2019 based on ad spend. Humira led the pack with more than 460 million U.S. dollars in TV ad expenditures that year, while Xeljanz and Eliquis spent a little over 180 and 140 million, respectively. All in all, the entire pharmaceutical industry spent 3.7 billion U.S dollars on TV advertising in 2019.
On average, pharma companies allocated more than 11 million U.S. dollars to their marketing budgets in 2018, representing a growth of roughly 30 percent over the preceding year. Compared to other types of health care companies, pharmaceutical manufacturers had the largest marketing budgets and the majority of pharma executives also indicated that their marketing allowances were set to increase.
Pharmaceutical marketing and advertising
As well as being advertised on TV, the pharmaceutical sector is actively promoted in medical and surgical journals. Advertising revenues generated via this medium reach well over 300 million U.S. dollars each year. By far, the largest amounts are devoted to advertising of antineoplastic agents – medicines used in cancer treatment. Bronchial steroids, antivirals, monoclonal antibodies and oral anticoagulants close the list of most advertised drug classes in health journals.On average, pharma companies allocated more than 11 million U.S. dollars to their marketing budgets in 2018, representing a growth of roughly 30 percent over the preceding year. Compared to other types of health care companies, pharmaceutical manufacturers had the largest marketing budgets and the majority of pharma executives also indicated that their marketing allowances were set to increase.
